Skip to content

MARTY Médicale

Active Private limited companyfounded 2021active for 4 yearsRue du Charnois 50, 1342 Ottignies-Louvain-la-NeuveKBO/BCE: BE 0778.411.538

Lifetime

4 annual accounts with figures on one time axis
peak of €80,457 in 2024
€76,102▼ 5.4%
peak of €59,593 in 2024
€50,432▼ 15.4%
peak of €77,936 in 2023
€72,961▼ 5.9%
€62,961▼ 18.6%
Board1 name since 2022
1 director
Documentsfilings and deeds
08-12-202554 days before the deadline
2025micro format
Dividend €55,000Debts from €77,388 to €62,961Cash from €32,916 to €57,225

Key points

from the 2025 annual accounts

Equity

€72,961 ▼ 5.9%
77,5282024+50,432Profit-55,000Dividend72,9612025

MARTY Médicale paid out €55,000 in dividends. That is 109% of the 2025 profit.

Turnover

≈ €170,000 estimated

The micro format states no turnover.

Filings

4 annual accounts since 2022
deadline2022202320242025

The last four annual accounts were filed 15 to 54 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,332 companies had the same profile as MARTY Médicale has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,332 companies, not a prediction for MARTY Médicale. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 300 sharesdeed of 13-12-2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0778411538
Registered office moved from Sint-Stevens-Woluwe to Limelette The registered office moved from Lenneke Marelaan 14, 1932 Sint-Stevens-Woluwe to rue du Charnois 50, 1342 Limelette · General meeting of 22-05-2023 · Gazette deed
Registered-office move General meeting of 22-05-2023 · Gazette deed
Incorporation Founding capital of €3,000, 300 shares · Founded by (comparant) · Registered office in the articles: Lenneke Marelaan 14 · published on 13-12-2021 · Gazette deed
All 10 events

Comparable companies

same main activity, similar in size and age
Company
MARTY Médicale Ottignies-Louvain-la-Neuve €135,922 €76,102 53.7% -
Gynécho-Lambot Ottignies-Louvain-la-Neuve €160,500 €73,753 21.4% -
GC Ronse €152,203 €79,756 57.0% -
Medicarl Anderlecht €121,995 €69,616 65.3% -
DOCTEUR HELENE HUVELLE Liège €141,401 €86,424 40.7% -
DOCTEUR AURELIE GILBERT Huy €127,628 €75,331 50.7% -
Dr Eline De Keyser Dermatoloog Ghent €115,000 €74,414 51.1% -

These companies have the same main activity as MARTY Médicale: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €115,000 and €161,000, founded between 2021 and 2022.

Official details

Source: KBO
Status
Active since 09-12-2021Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.329.777.3751342 Ottignies-Louvain-la-Neuve, registered on 09-12-2021
Financial year end
30 June
Peppol
Reachable since 22-12-2025
Company details

Annual accounts to 30-06-2025

€135,922▼ 12.3%
Filing
Filed on 08-12-2025, 54 days before the end of the filing period
Financials

Insights on MARTY Médicale

MARTY Médicale files the micro format. That format states no turnover. The gross margin rose from €42,063 in 2022 to €76,102 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MARTY Médicale

What is the company number of MARTY Médicale?
The company number of MARTY Médicale is 0778.411.538. The VAT number is the same number with BE in front: BE 0778.411.538.
Where is MARTY Médicale based?
The registered office is at Rue du Charnois 50, 1342 Ottignies-Louvain-la-Neuve.Company details
What does MARTY Médicale do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of MARTY Médicale?
MARTY Médicale is a private limited company (BV).
When was MARTY Médicale founded?
MARTY Médicale was founded on 09-12-2021.
Is MARTY Médicale still active?
Yes, MARTY Médicale is an active enterprise in the KBO register.
What is the turnover of MARTY Médicale?
The turnover in financial year 2025 is about €170,000. This figure is estimated from the gross margin of €76,102 and 33 comparable companies (NACE 862). It probably lies between €130,000 and €210,000.Financials
Is MARTY Médicale profitable?
In financial year 2025, MARTY Médicale made a profit of €50,432.
Where can I find the annual accounts of MARTY Médicale?
MARTY Médicale filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MARTY Médicale due?
MARTY Médicale must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.